FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2010271323> ?p ?o ?g. }

• W2010271323 endingPage "950" @default.
• W2010271323 startingPage "945" @default.
• W2010271323 abstract "Clinical trials show improvement in physical and health-related quality of life (HRQoL) measures in patients with psoriasis treated with biologics compared with placebo. However, these reports only give limited interpretation of the meaning of Dermatology Life Quality Index (DLQI) scores and provide limited comparison data.The aim of this paper is to identify which biological therapy provides the greatest improvement in HRQoL following treatment of patients with chronic plaque psoriasis, as assessed by the DLQI.We reviewed all data published up to August 2006 of randomized placebo-controlled trials (RCTs) of the four biologics currently licensed in some countries for clinical use in chronic plaque psoriasis (alefacept, efalizumab, etanercept and infliximab) which have used the DLQI as an outcome measure. The DLQI data were assessed based on overall improvement according to the DLQI descriptor bands and on clinically meaningful improvement of > or = 5.Fifteen peer-reviewed articles and 59 abstracts describing 11 multicentre, double-blind RCTs were reviewed. Treatment with any one of the four biologics led to a clinically meaningful improvement in the DLQI of > or = 5. However, when applying the DLQI banding concept, infliximab and etanercept provided the greatest improvement in the overall HRQoL from a 'very large effect on overall HRQoL' at baseline to 'a small effect on overall HRQoL' following treatment.The DLQI banding concept provides a further tool to assess the impact of biologics on HRQoL of patients with psoriasis. Based on retrospective application of DLQI bands to published RCT data, infliximab, followed by etanercept, showed the greatest improvement in the overall HRQoL paralleled by a 75% improvement in the Psoriasis Area and Severity Index. However, some publications did not provide absolute baseline DLQI values, making interpretation of data and comparison between the agents difficult. Side-to-side comparative studies between biologics and between biologics and nonbiological psoriasis treatments will aid evidence-based psoriasis management decisions in the future." @default.
• W2010271323 created "2016-06-24" @default.
• W2010271323 creator A5008906753 @default.
• W2010271323 creator A5071850174 @default.
• W2010271323 creator A5084805641 @default.
• W2010271323 date "2007-05-01" @default.
• W2010271323 modified "2023-10-18" @default.
• W2010271323 title "The Dermatology Life Quality Index: assessing the efficacy of biological therapies for psoriasis" @default.
• W2010271323 cites W1600222105 @default.
• W2010271323 cites W1977695408 @default.
• W2010271323 cites W1978428707 @default.
• W2010271323 cites W1996098475 @default.
• W2010271323 cites W2000902862 @default.
• W2010271323 cites W2009404271 @default.
• W2010271323 cites W2012581664 @default.
• W2010271323 cites W2012608901 @default.
• W2010271323 cites W2013361256 @default.
• W2010271323 cites W2019205814 @default.
• W2010271323 cites W2030298480 @default.
• W2010271323 cites W2034585843 @default.
• W2010271323 cites W2055018575 @default.
• W2010271323 cites W2069231021 @default.
• W2010271323 cites W2080165152 @default.
• W2010271323 cites W2086861262 @default.
• W2010271323 cites W2090313542 @default.
• W2010271323 cites W2091442391 @default.
• W2010271323 cites W2096991001 @default.
• W2010271323 cites W2098835966 @default.
• W2010271323 cites W2112629007 @default.
• W2010271323 cites W2129137973 @default.
• W2010271323 cites W2129412675 @default.
• W2010271323 cites W2139140379 @default.
• W2010271323 cites W2142466802 @default.
• W2010271323 cites W2164533070 @default.
• W2010271323 doi "https://doi.org/10.1111/j.1365-2133.2007.07817.x" @default.
• W2010271323 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17388922" @default.
• W2010271323 hasPublicationYear "2007" @default.
• W2010271323 type Work @default.
• W2010271323 sameAs 2010271323 @default.
• W2010271323 citedByCount "82" @default.
• W2010271323 countsByYear W20102713232012 @default.
• W2010271323 countsByYear W20102713232013 @default.
• W2010271323 countsByYear W20102713232014 @default.
• W2010271323 countsByYear W20102713232015 @default.
• W2010271323 countsByYear W20102713232016 @default.
• W2010271323 countsByYear W20102713232017 @default.
• W2010271323 countsByYear W20102713232018 @default.
• W2010271323 countsByYear W20102713232019 @default.
• W2010271323 countsByYear W20102713232020 @default.
• W2010271323 countsByYear W20102713232021 @default.
• W2010271323 countsByYear W20102713232022 @default.
• W2010271323 countsByYear W20102713232023 @default.
• W2010271323 crossrefType "journal-article" @default.
• W2010271323 hasAuthorship W2010271323A5008906753 @default.
• W2010271323 hasAuthorship W2010271323A5071850174 @default.
• W2010271323 hasAuthorship W2010271323A5084805641 @default.
• W2010271323 hasConcept C126322002 @default.
• W2010271323 hasConcept C142724271 @default.
• W2010271323 hasConcept C159110408 @default.
• W2010271323 hasConcept C16005928 @default.
• W2010271323 hasConcept C168563851 @default.
• W2010271323 hasConcept C1862650 @default.
• W2010271323 hasConcept C204787440 @default.
• W2010271323 hasConcept C27081682 @default.
• W2010271323 hasConcept C2776173921 @default.
• W2010271323 hasConcept C2777011040 @default.
• W2010271323 hasConcept C2777138892 @default.
• W2010271323 hasConcept C2777226972 @default.
• W2010271323 hasConcept C2777575956 @default.
• W2010271323 hasConcept C2779134260 @default.
• W2010271323 hasConcept C2779951463 @default.
• W2010271323 hasConcept C2780564577 @default.
• W2010271323 hasConcept C535046627 @default.
• W2010271323 hasConcept C71924100 @default.
• W2010271323 hasConceptScore W2010271323C126322002 @default.
• W2010271323 hasConceptScore W2010271323C142724271 @default.
• W2010271323 hasConceptScore W2010271323C159110408 @default.
• W2010271323 hasConceptScore W2010271323C16005928 @default.
• W2010271323 hasConceptScore W2010271323C168563851 @default.
• W2010271323 hasConceptScore W2010271323C1862650 @default.
• W2010271323 hasConceptScore W2010271323C204787440 @default.
• W2010271323 hasConceptScore W2010271323C27081682 @default.
• W2010271323 hasConceptScore W2010271323C2776173921 @default.
• W2010271323 hasConceptScore W2010271323C2777011040 @default.
• W2010271323 hasConceptScore W2010271323C2777138892 @default.
• W2010271323 hasConceptScore W2010271323C2777226972 @default.
• W2010271323 hasConceptScore W2010271323C2777575956 @default.
• W2010271323 hasConceptScore W2010271323C2779134260 @default.
• W2010271323 hasConceptScore W2010271323C2779951463 @default.
• W2010271323 hasConceptScore W2010271323C2780564577 @default.
• W2010271323 hasConceptScore W2010271323C535046627 @default.
• W2010271323 hasConceptScore W2010271323C71924100 @default.
• W2010271323 hasIssue "5" @default.
• W2010271323 hasLocation W20102713231 @default.
• W2010271323 hasLocation W20102713232 @default.
• W2010271323 hasOpenAccess W2010271323 @default.
• W2010271323 hasPrimaryLocation W20102713231 @default.
• W2010271323 hasRelatedWork W2033854858 @default.

• next